Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy

References

• Ahmad N, Ahmad R, Alam MA, et al. (2019). Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Int J Biol Macromol 128:825–38.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Naqvi AA, et al. (2016). Quantification of rutin in rat's brain by UHPLC/ESI-Q-TOF-MS/MS after intranasal administration of rutin loaded chitosan nanoparticles. EXCLI J 15:518–31.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Alam MA, et al. (2018a). Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles. Chem Central J 12:65.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Alam MA, Ahmad R, et al. (2018b). Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Artif Cells Nanomed Biotechnol 46:432–46.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Alam MA, Ahmad R, et al. (2018c). Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. J Microencapsul 35:327–43.
   PubMed Web of Science ®Google Scholar
• Chan LMS, Lowes S, Hirst BH. (2004). The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharma Sci 21:25–51.
   PubMed Web of Science ®Google Scholar
• Dokania S, Joshi AK. (2015). Self-microemulsifying drug delivery system (SMEDDS)-challenges and road ahead. Drug Deliv 22:675–90.
   PubMed Web of Science ®Google Scholar
• Feng SS, Mei L, Anitha P, et al. (2009). Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 30:3297–306.
   PubMed Web of Science ®Google Scholar
• Gao F, Zhang Z, Bu H, et al. (2011). Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism. J Control Release 149:168–74.
   PubMed Web of Science ®Google Scholar
• Ghadi R, Dand N. (2017). BCS class IV drugs: Highly notorious candidates for formulation development. J Controlled Release 248:71–95.
   PubMed Web of Science ®Google Scholar
• Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 58:173–82.
   PubMed Web of Science ®Google Scholar
• Hu K, Cao S, Hu F, et al. (2012). Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int J Nanomedicine 7:3537–45.
   PubMed Web of Science ®Google Scholar
• Lavelle F, Bissery MC, Combeau C, et al. (1995). Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 22:3–16.
   Web of Science ®Google Scholar
• Luo C, Sun J, Du Y, et al. (2014). Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy. J Control Release 176:94–103.
   PubMed Web of Science ®Google Scholar
• MacConnachie AM. (1997). Docetaxel (taxotere, Rhone-Poulenc Rorer). Intensive Crit Care Nurs 13:119–20.
   PubMedGoogle Scholar
• Malingre MM, Ten Bokkel Huinink WW, Mackay M, et al. (2001). Pharmacokinetics of oral cyclosporin A when co-administered to enhance the absorption of orally administered docetaxel. Eur J Clin Pharmacol 57:305–7.
   PubMed Web of Science ®Google Scholar
• McEntee M, Silverman JA, Rassnick K, et al. (2003). Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats. Vet Comp Oncol 1:105–12.
   PubMedGoogle Scholar
• Oostendorp RL, Buckle T, Lambert G, et al. (2011). Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice. Invest New Drugs 29:768–76.
   PubMed Web of Science ®Google Scholar
• Paolini M, Poul L, Berjaud C, et al. (2017). Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel. Int J Nanomedicine 12:5537–56.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. (2007). Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6:231–48.
   PubMed Web of Science ®Google Scholar
• Rahman A, Hussain A, Hussain S, et al. (2013). Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm 39:1–19.
   PubMed Web of Science ®Google Scholar
• Seo YG, Kim DH, Ramasamy T, et al. (2013). Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharm 452:412–20.
   PubMed Web of Science ®Google Scholar
• Singh B, Singh R, Bandyopadhyay S, et al. (2013). Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf B Biointerfaces 101:465–74.
   PubMed Web of Science ®Google Scholar
• Sohail MF, Rehman M, Sarwar HS, et al. (2018). Advancements in the oral delivery of docetaxel: challenges, current state-of-the-art and future trends. Int J Nanomed 13:3145–61.
   PubMed Web of Science ®Google Scholar
• Sun B, Luo C, Li L, et al. (2016). Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel. Colloids Surf B Biointerfaces 143:47–55.
   PubMed Web of Science ®Google Scholar
• Veltkamp SA, Thijssen B, Garrigue JS, et al. (2006). A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer. Br J Cancer 95:729–34.
   PubMed Web of Science ®Google Scholar
• Yang S, Gursoy RN, Lambert G, et al. (2004). Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm Res 21:261–70.
   PubMed Web of Science ®Google Scholar
• Yin YM, Cui FD, Mu CF, et al. (2009). Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 140:86–94.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Benet LZ. (2001). The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin Pharma 40:159–68.
   Google Scholar
• Zhang Y, Li X, Zhou Y, et al. (2010). Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier. Mol Pharm 7:1169–82.
   PubMed Web of Science ®Google Scholar
• Zhang D, Pan X, Wang S, et al. (2015). Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus. Mol Pharm 12:2337–51.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang C, Chow AH, et al. (2010). Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int J Pharm 383:170–7.
   PubMed Web of Science ®Google Scholar